Skin & hair

A Red, Scaly Patch That Persists — Could Be Skin Cancer

Save

Eczema, psoriasis, and fungal infections cause most persistent red scaly patches — but superficial basal cell carcinoma and squamous cell carcinoma in situ can look exactly the same. The tell is not the appearance; it is a patch that stays put and won't heal despite treatment. Here is how to tell benign from concerning, and why the answer comes from a biopsy.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Could a red, scaly patch that won't go away be skin cancer?

Yes — though most persistent red scaly patches are not cancer. Common, benign conditions like eczema, psoriasis, and ringworm cause the great majority of them. But two skin cancers — superficial basal cell carcinoma and squamous cell carcinoma in its earliest, in-place form — can look and feel almost identical to those benign rashes. Nothing about the surface reliably separates them, which is why a description or a photo cannot settle the question.

The most useful signal is behavior over time. A rash that flares and fades, itches, appears in typical spots, and improves with the right cream is usually benign. A patch that stays in exactly one place, slowly widens, and refuses to clear despite weeks of treatment is the one that earns a biopsy — regardless of how ordinary it looks.

What usually causes a persistent red scaly patch?

Most long-lasting red scaly patches come from chronic inflammatory or infectious skin conditions rather than cancer. Eczema (atopic dermatitis) is a chronic, itchy, inflammatory condition that tends to flare and settle and often starts in childhood 1. Psoriasis produces thicker, silvery-scaled plaques, classically on the elbows, knees, and scalp. And ringworm — a fungal infection despite the name — makes a circular, scaly, often ring-shaped patch that spreads outward and can pass between people, pets, and surfaces 2.

These have real treatments, which is itself part of the diagnostic clue. A genuine fungal patch usually responds to an antifungal, and eczema usually calms with moisturizer and anti-inflammatory care. When a patch treated correctly as one of these simply does not budge, that failure to respond is a reason to reconsider the diagnosis rather than to keep repeating the same cream.

When a red scaly patch is more likely skin cancer

Certain features shift the odds toward cancer, though none is proof. A superficial basal cell carcinoma is often a flat, pink-to-red, slightly scaly patch on the trunk or shoulders that slowly enlarges over months and may have a fine, slightly raised, pearly or rolled edge. Squamous cell carcinoma in situ tends to be a well-defined red scaly patch that persists and grows, sometimes on sun-exposed skin. Both are diagnosed by biopsy and treated by removal, with Mohs surgery reserved for higher-risk or facial tumors 34.

The pattern that should prompt evaluation: a solitary patch — not a symmetric rash on both sides of the body — that is fixed in one location, slowly widening, that does not itch the way eczema does, that may bleed when rubbed, and that does not clear with the treatment a benign version would. A scar like patch appeared on skin without an injury, or a spot that keeps returning after it seemed to heal, belongs in the same category, as does a shiny bump with tiny blood vessels forming at the edge.

How to tell them apart: you photograph, they biopsy

You cannot diagnose this at home, and neither can a clinician from a photograph — but you can gather the evidence that makes the visit decisive. Because a benign rash and an early skin cancer overlap so much, the deciding step is a biopsy: a small sample of the patch examined under a microscope. Any patch treated as eczema or a fungal infection that has not cleared in the weeks it should have is a candidate for one 5.

The practical rule dermatologists use is time-bound. Give a reasonable treatment a fair trial, and if the patch is still there — or has grown — the diagnosis is revisited with a biopsy rather than another round of cream. That is not a failure of the first guess; persistent, treatment-resistant patches are exactly the ones a biopsy was designed to sort out.

How to photograph and track the patch

Documenting the patch turns a vague worry into something a dermatologist can act on. Photograph it in even light with a ruler or coin beside it for scale, and write down the date. Re-photograph every couple of weeks from the same distance, and keep a short note of what you have tried — which cream, for how long — and whether it helped.

  • Measure it. A patch that is visibly wider than last month is the clearest sign of a lesion that needs sampling.
  • Record treatments and dates. "Two weeks of an antifungal, no change" is powerful information at the visit.
  • Note bleeding or a rolled edge. These shift a patch from routine to worth showing soon.

A patch that hasn't cleared after a fair trial of the right treatment is the one to get biopsied.

How these are treated once there's a diagnosis

Treatment depends entirely on what the biopsy shows, which is why the diagnosis comes first. Benign conditions have their own ladders: eczema is managed with moisturizers, topical corticosteroids, and other topical anti-inflammatory options, with more advanced treatment reserved for stubborn, widespread disease 6; ringworm clears with antifungals. None of these requires surgery.

Skin cancers are removed. Superficial basal cell carcinoma and squamous cell carcinoma in situ are usually treated with surgical excision; for select thin, superficial tumors, topical or light-based (photodynamic) therapies have a role, and Mohs micrographic surgery is reserved for high-risk or cosmetically sensitive sites like the face 34. The earlier one of these is caught, the smaller and simpler the removal tends to be — another reason not to sit on a patch that won't clear.

What raises the risk, and can you prevent it?

The strongest changeable risk for these skin cancers is ultraviolet exposure — years of sun and any indoor tanning — so sun protection is the prevention step with the most evidence behind it 7. Fair skin that burns easily, older age, a history of frequent sunburns, and a suppressed immune system also raise the odds. Basal cell carcinoma is very common and usually slow-growing; how much it matters, and when, is the substance of the question is basal cell carcinoma dangerous, covered in its own explainer.

None of this identifies your patch. Risk factors change the odds; they do not make a diagnosis. A red, scaly patch that persists deserves the same in-person evaluation whether or not you have any of them.

Common questions

There is no exact cutoff, but a patch that hasn't improved after a few weeks of appropriate treatment — the right antifungal, or moisturizer and anti-inflammatory care for eczema — is worth a professional look. Benign rashes usually respond in that window. A patch that stays put, keeps widening, or comes back in the same spot is the one to have examined.

You often can't by looking, which is the honest answer. Eczema and psoriasis tend to itch, appear in typical spots, come and go, and improve with treatment. A skin cancer is more often a single, fixed patch that slowly enlarges and resists treatment. But these overlap enough that a biopsy — not the appearance — is what actually settles it.

Usually not, especially early. Superficial basal cell carcinoma and squamous cell carcinoma in situ are often painless and may only be a bit scaly or occasionally bleed when rubbed. The absence of pain is not reassuring — many early skin cancers don't hurt at all. Pain, tenderness, or a non-healing sore are reasons to be seen sooner, not the only ones.

The dermatologist examines the patch closely, often with dermoscopy, asks how long it's been there and what you've tried, and — if it's uncertain or looks like it could be cancer — takes a small biopsy under local anesthetic. The sample goes to a pathologist, and treatment is decided from that result. Bringing dated photos and your treatment history makes the visit faster.

It's reasonable to try a benign explanation first — an antifungal or eczema care — for a short, defined trial. But treating blindly for months is how an early skin cancer gets missed. If a patch hasn't cleared after a fair trial, the next step is a biopsy to find out what it actually is, not another cream aimed at a guess.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a persistent patch needs a prompt look

  • A single red or scaly patch that slowly widens over weeks to months and stays in the same spot
  • A patch that bleeds when rubbed, crusts over, or forms a sore that keeps reopening
  • A red scaly patch that does not clear after a fair trial of the correct treatment for eczema or a fungal infection
  • A pearly, rolled, or scar-like edge developing around the patch

This article is for education and cannot diagnose a skin patch — benign rashes and early skin cancers genuinely look alike. Only an in-person exam and, when needed, a biopsy can tell them apart. A patch that won't clear is a reason to see a dermatologist, not to keep guessing at home.

References

  1. 1.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Atopic Dermatitis (Eczema). NIH / NIAMS. linkAtopic dermatitis (eczema) as a chronic, itchy, inflammatory skin condition with typical childhood onset and a flare/remission course; used to describe a common benign cause of a persistent red scaly patch.
  2. 2.Centers for Disease Control and Prevention (2024). Ringworm Basics. CDC. linkRingworm (tinea) as a common dermatophyte infection presenting as a circular scaly rash spread by contact with people, animals, or surfaces; used as a benign, treatable mimic.
  3. 3.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.006Basal cell carcinoma is diagnosed by biopsy and treated by surgical excision, with Mohs for high-risk/facial tumors and a limited role for topical and photodynamic therapies; used for the BCC identification and treatment statements.
  4. 4.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.007Cutaneous squamous cell carcinoma management — standard excision margins for low-risk tumors and Mohs for high-risk tumors; used for the squamous-cell-carcinoma-in-situ identification and treatment statements.
  5. 5.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. linkSkin biopsy as the diagnostic step for an uncertain lesion, and the selection among techniques; used for the point that a persistent, treatment-resistant patch should be biopsied.
  6. 6.Sidbury R, Alikhan A, Bercovitch L, et al. (2023). Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2022.12.029First-line topical management of adult eczema (moisturizers, bathing, topical corticosteroids, topical calcineurin inhibitors); used for the benign-condition treatment ladder.
  7. 7.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Skin Cancer Prevention (PDQ®)–Health Professional Version. NIH / National Cancer Institute. linkAvoidance of UV radiation (sun, sunlamps, tanning beds) as a modifiable skin-cancer risk factor; used for the risk and prevention section.

7 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy